Viridien
Short position disclosed on September 22, 2026.
Evolution of the disclosed total
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Capital Fund Management | 1.52% | +0.95 pt | September 15, 2026 | ||
| Marshall Wace LLP | 1.40% | -0.11 pt | September 22, 2026 | ||
| Citadel Advisors LLC | 1.12% | +0.34 pt | September 21, 2026 | ||
| Worldquant, LLC | 1.03% | new | September 22, 2026 | ||
| Walleye Capital LLC | 0.71% | new | August 17, 2026 | AMF | |
| TWO Sigma Investments, LP | 0.70% | new | August 19, 2026 | AMF | |
| Tudor Capital Europe LLP | 0.70% | new | September 21, 2026 | ||
| Acadian Asset Management LLC | 0.64% | new | September 22, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 7,682 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| March 13, 2014 | Bluecrest Capital Management Limited | 0.70% | March 25, 2014 | |
| March 10, 2014 | Marshall Wace LLP | 0.82% | April 18, 2014 | |
| March 3, 2014 | Bluecrest Capital Management Limited | 0.63% | March 25, 2014 | |
| February 28, 2014 | Marshall Wace LLP | 0.73% | April 18, 2014 | |
| February 28, 2014 | Oxford Asset Management LLP | 0.52% | April 28, 2014 | |
| February 27, 2014 | Marshall Wace LLP | 0.82% | April 18, 2014 | |
| February 26, 2014 | Bluecrest Capital Management Limited | 0.58% | March 25, 2014 | |
| February 25, 2014 | AQR Capital Management, LLC | 1.70% | September 16, 2015 | |
| February 25, 2014 | Marshall Wace LLP | 0.79% | April 18, 2014 | |
| February 25, 2014 | Bluecrest Capital Management Limited | 0.49% | February 27, 2014 | |
| February 20, 2014 | AQR Capital Management, LLC | 1.61% | September 16, 2015 | |
| February 20, 2014 | Marshall Wace LLP | 0.88% | April 18, 2014 | |
| February 19, 2014 | AQR Capital Management, LLC | 1.58% | September 16, 2015 | |
| February 18, 2014 | Marshall Wace LLP | 0.91% | April 18, 2014 | |
| February 13, 2014 | Marshall Wace LLP | 0.83% | April 18, 2014 | |
| February 12, 2014 | Marshall Wace LLP | 0.78% | April 18, 2014 | |
| February 11, 2014 | Marshall Wace LLP | 0.80% | April 18, 2014 | |
| February 11, 2014 | Jpmorgan Asset Management (UK) Limited | 0.55% | November 24, 2014 | |
| February 7, 2014 | Bluecrest Capital Management Limited | 0.55% | February 27, 2014 | |
| February 6, 2014 | AQR Capital Management, LLC | 1.40% | September 16, 2015 | |
| February 6, 2014 | Marshall Wace LLP | 0.76% | April 18, 2014 | |
| February 3, 2014 | AQR Capital Management, LLC | 1.30% | September 16, 2015 | |
| February 3, 2014 | Bluecrest Capital Management Limited | 0.61% | February 27, 2014 | |
| January 28, 2014 | AQR Capital Management, LLC | 1.21% | September 16, 2015 | |
| January 22, 2014 | Bluecrest Capital Management Limited | 0.59% | February 27, 2014 | |
| January 21, 2014 | Jpmorgan Asset Management (UK) Limited | 0.62% | November 24, 2014 | |
| January 20, 2014 | Jpmorgan Asset Management (UK) Limited | 0.56% | November 24, 2014 | |
| January 17, 2014 | Marshall Wace LLP | 0.88% | April 18, 2014 | |
| January 14, 2014 | Marshall Wace LLP | 0.96% | April 18, 2014 | |
| January 9, 2014 | AQR Capital Management, LLC | 1.12% | September 16, 2015 | |
| January 9, 2014 | AKO Capital LLP | 0.71% | May 12, 2014 | |
| January 9, 2014 | Bluecrest Capital Management Limited | 0.61% | February 27, 2014 | |
| January 8, 2014 | AKO Capital LLP | 0.97% | May 12, 2014 | |
| January 7, 2014 | AKO Capital LLP | 1.19% | May 12, 2014 | |
| January 6, 2014 | AQR Capital Management, LLC | 1.02% | September 16, 2015 | |
| January 6, 2014 | Bluecrest Capital Management Limited | 0.50% | February 27, 2014 | |
| December 27, 2013 | AQR Capital Management, LLC | 0.98% | September 16, 2015 | |
| December 23, 2013 | Marshall Wace LLP | 1.04% | April 18, 2014 | |
| December 20, 2013 | Marshall Wace LLP | 0.99% | April 18, 2014 | |
| December 19, 2013 | Marshall Wace LLP | 0.85% | April 18, 2014 | |
| December 18, 2013 | Marshall Wace LLP | 0.65% | April 18, 2014 | |
| December 18, 2013 | Blackrock Investment Management (UK) Limited | 0.31% | December 20, 2013 | |
| December 17, 2013 | AKO Capital LLP | 1.26% | May 12, 2014 | |
| December 16, 2013 | AQR Capital Management, LLC | 1.02% | September 16, 2015 | |
| December 16, 2013 | Blackrock Investment Management (UK) Limited | 0.58% | December 20, 2013 | |
| December 10, 2013 | Marshall Wace LLP | 0.70% | April 18, 2014 | |
| December 10, 2013 | Blackrock Investment Management (UK) Limited | 0.61% | December 20, 2013 | |
| December 6, 2013 | Marshall Wace LLP | 0.60% | April 18, 2014 | |
| December 3, 2013 | AQR Capital Management, LLC | 0.92% | September 16, 2015 | |
| December 3, 2013 | Marshall Wace LLP | 0.54% | April 18, 2014 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 2491 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.35% of the capital sold short
- Valeo 11.29% of the capital sold short
- Renault 9.50% of the capital sold short
- Teleperformance 6.31% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Abivax 4.47% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- DBV Technologies 4.21% of the capital sold short
- VusionGroup 3.91% of the capital sold short
- Sopra Steria Group 3.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at September 22, 2026, https://www.quivad.com/action/viridien?page=49